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Homozygous deletions (HD) of human CDKN2A and neighboring regions on the p arm of 
Chromosome 9 have been previously reported in some cancers but a pan-cancer analysis of the 
aberrations of this locus is lacking. Here we analyzed the copy number variations that include 
CDKN2A locus using data acquired with an Affymetrix SNP6.0 array and deposited on the 
Catalogue of Somatic Mutations in Cancer (COSMIC) database. We find that inactivation of 
CDKN2A by HD is not cancer specific. A majority of HDs of this locus have a median range of 
1,255,650 base pairs. We then mapped the positions of breakpoints of these deletions on both the 
telomere and centromere proximal sides of CDKN2A. Remarkably, most of the telomere 
proximal breakpoints map to a narrow region of the chromosome where the genes MTAP and 
MIR31HG are located. The centromere proximal breakpoints of the deletions are distributed over 
a wider chromosomal region. This comprehensive analysis shows that inactivation of CDKN2A 
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Deoxyribonucleic acid (DNA) is a molecule composed of two antiparallel strands of 
sugar phosphate groups that twist to form a double helix held together by hydrogen bonds. 
Hydrogen bonds are between complementary nitrogenous base pairs, adenine (A) to thymine (T) 
and cytosine (C) to guanine (G). Two hydrogen bonds connect A to T and three hydrogen bonds 
connect C to G. DNA is the genetic material that serves as instructions for all cellular processes. 
The information encoded in DNA (the genome) is transcribed into mRNA and translated into 
proteins. During cellular replication a copy of the genome is passed onto progeny (TUBBS AND 
NUSSENZWEIG 2017). DNA is constantly exposed to exogenous and endogenous damage. 
Exogenous agents include ionizing radiation (IR), X-rays, ultraviolet (UV) light, oxidative 
damage during metabolism, base hydrolysis and other various chemical agents (FRIEDBERG 
2008). Endogenous or spontaneous damage arises mainly from mistakes made by the DNA 
replicative machinery when the genome is copied during cell division. Exogenous and 
endogenous agents can cause genetic changes in the DNA genome that can lead to accumulation 
of mutations and cancer (FRIEDBERG 2008). The DNA damage and repair mechanisms play a 
critical part in maintaining genome stability (WANG AND VASQUEZ 2017). 
 
Types of DNA damage and their consequences 
The DNA genome is subjected to many forms of DNA damage daily (Figure 1) (Biology 
Learning Center). Indeed, in a single day approximately 70,000 lesions occur in each human cell, 
and a clear majority (75%) of the lesions are DNA single stranded breaks (SSBs) (LINDAHL AND 
BARNES 2000; FRIEDBERG 2008). A single stranded DNA break occurs when one strand that 
makes up the double stranded DNA is severed. In a few instances, SSBs may be converted into 
DNA double stranded breaks (DSBs). A double stranded DNA break arises when both strands of 
the DNA helix are severed. Both SSBs and DSBs can result from exogenous agents such as 
ionizing radiation (IR) induced directly or indirectly from reactive oxygen species (ROS). Both 
types of breaks compromise the genomic integrity of the genome. DSBs are the most dangerous 
type of lesions if left unrepaired or repaired incorrectly (WARD 1988). Unlike SSBs which can be 
repaired from the non-broken template, DSBs must be repaired by looking for homology 
elsewhere in the genome. Therefore, repair of DSBs is more mutagenic than SSBs. When a DSB 
is repaired incorrectly, it can induce mutations and chromosomal rearrangements such as 
deletions, duplications, inversions and translocations. A deletion or duplication occurs when a 
segment of a chromosome is lost or copied respectively. An inversion occurs when a segment of 
a chromosome is reversed, and the orientation is flipped. Translocation occurs when one segment 
of a chromosome is exchanged with a segment from another chromosome. These events can lead 
to genomic instability which may lead to cell death or cancer (JACKSON AND BARTEK 2009). 
Although most DSBs are repaired correctly and do not lead to chromosomal aberrations, 
incorrect repair can occur when the cell encounters mutations in components of the repair 
machinery. 
 
DSBs can be categorized as one-ended or two-ended DSBs. Exogenous damage such 
as reactive oxygen species (ROS) generated by ionization radiation results in two-ended DSBs. 
Two-ended DSBs are generated when both strands of the DNA double helix are broken 
simultaneously at the same position or near the same proximity. Endogenous damage to DNA 
usually results in one-ended DSBs. A vast majority of one-ended 
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DSBs occurs during DNA replication, when a single stranded DNA break left unrepaired 
encounters a DNA replication fork triggering fork stalling or collapse. One-ended DSBs can also 
arise when a DNA replication fork stalls and a nuclease degrades one of the chromosome arms. 
Unlike two ended-DSBs, one ended DSBs are more problematic to repair because the second end 
does not exist (RANJHA et al. 2018). 
 
The processing and repair of DSBs becomes very important because unrepaired or 
inappropriately repaired DNA DSBs can lead to mutations and chromosomal aberrations that 
may result in cell death or ultimately give rise to cancer. DNA repair pathways are highly 
conserved in eukaryotic organisms. DNA damage and repair were first studied in model 
organisms such as in the yeasts (Saccharomyces cerevisiae or Schizosaccharomyces pombe) and 
further extrapolated to higher level eukaryotic organisms such as humans. All eukaryotic 
organisms share similar DNA repair mechanisms but depending on the complexity of the 
organism, mechanism of break formation and repair as well as the preferred stage of the cell 
cycle may differ (PASTINK et al. 2001). This introduction will focus on DNA double stranded 
breaks and the different mechanisms of repair in human cells with emphasis on how 
inappropriate repair of chromosomal breaks leads to alteration of chromosomal copy number and 
cancer. These forms of chromosomal aberrations or copy number variations (CNVs) vary in size 
from 1 kilobases to several megabases in length. A high level of CNVs is associated with cancer. 
 
Cancer is a complex disease characterized by the lifelong accumulation of mutations and 
inappropriately repaired DNA damage resulting in alteration of the cellular machinery and 
leading to uncontrolled cell division. In addition to mutation accumulation (one base pair 
change), cancer cells show a high level of chromosomal aberrations such as loss of 
heterozygosity, homozygous deletion, and amplification. Loss of heterozygosity is a genetic 
event that leads to loss of one copy of a genetic region. Homozygous deletion constitutes the loss 
of both copies of the genetic region. Amplification is an event that results in gain of more than 
two copies of a genetic region. The chromosome copy number in normal diploid cells is fine- 
tuned at two per cell. Any alteration from this ratio will result in inappropriate gene expression 
of the type seen in cancer cells. 
 
In all cancer cells, part of the genome is either amplified or deleted to some degree 
(Figure 2), a process known as cellular transformation. There is a complex pattern between 
amplification and deletion that occurs across samples of cancer cells. Certain regions of the 
genome are more prone to have many chromosomal aberrations while other regions only have a 
few. Some regions of the genome consist of large deletions compared to short deletions. And 
some regions of the genome comprise large amplifications compared to other regions that show 
only a few amplifications. There may be a correlation between these observations (KASHIWAGI 
AND UCHIDA 2000). Not every gene that is amplified or deleted causes genomic disorders. 
Rather, mutations of certain key genes serve as drivers for rapid mutation accumulation. 
Duplication and deletions involving these genes gives rise to cancer and other genomic disorders 
(LUPSKI 1998; KENNEDY et al. 2012). 
 
Cell cycle regulation and defects in cancer cells 
Normal cells grow, divide and commit programmed cell death which is controlled by 
the cell cycle. The cell cycle must be tightly regulated as it governs DNA replication and cell 
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division. The cell cycle is made up of two distinct phases, interphase (G1, S and G2 phases) and 
the mitotic (M) phase. The M phase can be further divided into prophase, metaphase, anaphase, 
telophase and cytokinesis. During interphase, specifically in S phase DNA replication occurs 
and during the mitotic (M) phase the replicated DNA is divided equally between the two 
daughter cells (PINES 1994a; PINES AND HUNTER 1994). 
 
Throughout the cell cycle there are cell cycle checkpoints in place to maintain 
genomic integrity. Cells are in constant threat of endogenous and exogenous damage. Most 
damage is detected during or immediately after S-phase therefore the most important checkpoint 
is G2 and to a second degree an intra-S phase checkpoint. The checkpoints serve as a 
surveillance system, they asses the cell progression and detect DNA damage. If a checkpoint 
detects DNA damage, it can do one of two things: arrest cell cycle and recruit machineries to 
repair the damage or, if damage cannot be fixed stimulate apoptosis which is programmed cell 
death. Cancerous cells are not responsive to many of these checkpoints (VISCONTI et al. 2016). 
Mutations in two types of cell cycle regulators, proto-oncogenes and tumor suppressor genes 
may give rise to cancer. Proto-oncogenes are genes that are responsible for cell growth. A 
mutation in a proto-oncogene can activate it to become an oncogene that results in rapid cell 
growth. Tumor suppressor genes (or checkpoint genes) are genes responsible for slowing down 
cell division, allowing damaged DNA to be repaired or to allow for cell death if the damage 
cannot be repaired. A mutation in a tumor suppressor gene can allow bypass of cellular 
surveillance machinery. 
 
In addition to checkpoints, the cell cycle is further regulated by certain cyclin 
dependent kinases (CDKs). CDKs belongs to a family of serine/threonine kinases, that relies on 
the binding of specific regulatory subunits known as cyclins for kinase activity (PINES 1994b). 
The CDK phosphorylates and modifies the function of different targets throughout the cell cycle 
to drive the cell cycle forward. Therefore, the CDK can be thought as the master regulator of the 
cell cycle. Mutations in CDKs or their associated cyclins have been identified in cancer cells. 
Only certain CDK-cyclin complexes are found to be directly involved in regulating the cell 
cycle. Specific cyclins are synthesized and destroyed in the cell at certain stages of the cell cycle 
to allow passage of the cell through the different stages of the cycle (MALUMBRES AND 
BARBACID 2009; MALUMBRES et al. 2009). Different CDK-cyclin complexes are involved in 
initiating DNA synthesis (S phase) and mitotic (M) phase (PINES 1994a). 
 
CDKs can also bind inhibitor proteins which function to inhibit cyclin dependent 
kinase activity. For example, certain CDK inhibitors prevents the transition from G1 to S and 
G2 to M in the presence of DNA damage. CDK inhibitors are involved in cell cycle arrest, to 
allow cells to repair damage DNA and prevent damage DNA being passed down to the daughter 
cells(MALUMBRES AND BARBACID 2009; MALUMBRES et al. 2009). Therefore, they can be 
thought as checkpoint genes. The CDKN2A (cyclin dependent kinase inhibitor 2A) is a CDK1 
inhibitor that inhibits the G1/S transition. 
 
Cell cycle deregulation is one of the hallmarks of cancer. Tumor cells accumulate 
mutations, that results in three cell cycle defects: unscheduled proliferation, genomic instability 
and chromosomal instability. Genomic instability (GIN) refers to the increase tendency of 
mutations in the genome and chromosomal aberrations. Chromosomal instability (CIN), a type 
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of genomic instability, is characterized by altered chromosomal number (MALUMBRES AND 
BARBACID 2009; MALUMBRES et al. 2009). Mis-regulation of CDKs have been associated with 
unscheduled proliferation, GIN and CIN (MALUMBRES AND BARBACID 2005). 
 
Mechanisms of DNA damage repair 
To maintain genomic stability, higher level eukaryotic organisms have developed 
multiple mechanism to repair damaged DNA with minimal loss of genetic information 
(JACKSON AND BARTEK 2009; LUKAS AND BARTEK 2009). The three major DNA excision repair 
pathways that repair base alterations are base excision repair (BER), mismatch repair (MMR), 
and nucleotide excision repair (NER). BER is responsible for the repair of altered DNA bases. 
MMR is responsible for recognizing and repairing base mismatches during DNA replication. 
NER is responsible for removing and repairing DNA damages induced by ultraviolet light (UV), 
consisting of thymidine dimers. DNA excision repair pathways maintain the genomic integrity 
of DNA, prevent mutations and development of cancer and genomic disorders. 
 
The mechanisms for repair of DNA DSBs differ from the DNA excision repair pathways. 
Higher level eukaryotic organisms are equipped with two major processes for repair of DNA 
double stranded breaks, homologous recombination (HR) and nonhomologous DNA end joining 
(NHEJ) (TUBBS AND NUSSENZWEIG 2017). In homologous recombination (HR) the missing 
information resulting from a DSB is copied from the undamaged sister chromatid (Figure 3). 
Thus, HR provides high fidelity, ensuring accurate repair and restoring genetic information. 
Since HR is template-dependent, HR operates during the S and G2 phase after DNA replication 
when the sister chromatid is available (ORTHWEIN et al. 2015). HR can repair both one- and- two 
ended DSBs (KOWALCZYKOWSKI 2015; CHANG et al. 2017). Homologous recombination is used 
to rescue stalled or collapsed replication forks which generally produce one ended breaks that 
cannot be repaired by the NHEJ pathway which requires two ended breaks (RANJHA et al. 2018). 
We and others have previously shown that mutations in key genes that control the fidelity of 
replication and facilitate accurate DNA damage repair increase the numbers of chromosomal 
aberrations or CNVs (LI et al. 2013; BHATTACHARJEE AND NANDI 2016; HROMAS et al. 2016). 
 
The end-joining pathways can be further classified as canonical non-homologous end- 
joining and alternative nonhomologous end-joining (alt-NHEJ) also known as microhomology- 
mediated end-joining (MMEJ). NHEJ involves the direct ligation of the DSB ends and requires 
no homology for repair. NHEJ is template-independent, it does not require the sister chromatid 
for repair and can operate at any stage of the cell cycle. NHEJ is subjected to large deletions and 
chromosomal rearrangements leading to genetic information loss (CHANG et al. 2017). When 
both ends of a single DSB are present, they can simply be ligated together via NHEJ, however 
when multiple DSB breaks are present this becomes problematic for NHEJ. NHEJ can rejoin 
wrong DNA ends together leading to chromosomal rearrangements such as translocation 
(KOWALCZYKOWSKI 2015). The microhomology-mediated DSB repair pathway have similarities 
with both NHEJ and HR. MMEJ also involves the direct ligation of the DSB ends but requires 2- 
5 base pairs (bp) of homology for repair. The repair pathways by these mechanisms are fast but 
potentially mutagenic (RANJHA et al. 2018). 
 
Whether the cell employs HR or NHEJ for repair of DNA DSBs depends largely on the 
nature of the DSB ends. Extensive DNA end resection commits the cell to repair via HR and at 
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the same time inhibits NHEJ. NHEJ is not able to ligate DNA ends in the presence of DNA end 
resection. HR utilizes the exposed tracts of ssDNA for homology search (SYMINGTON AND 
GAUTIER 2011; CHAPMAN et al. 2012; SHIBATA 2017). Activation of CDK-cyclin complex 
initiates DNA end resection in the S and G2 phase of the cell cycle (WANG et al. 2018). 
 
Inactivation of the tumor suppressor CDKN2A in cancer cells 
As noted earlier, it has been long appreciated that the most represented mutations in 
cancer cells are of genes that control the cell cycle and those involved in DNA damage repair. 
For example, p53 mutations are identified in over 50% of cancers (BIEGING et al. 2014). The 
second most represented genetic aberration in cancers is the CDKN2A locus which is found on 
Ch9p21 (ORTEGA et al. 2002; KIM AND SHARPLESS 2006; POI et al. 2015). CDKN2A encodes 
three different tumor suppressors: ARF which promotes p53 stabilization, and p15 and p16 
which are inhibitors of Cyclin D/CDK4/6. The types of chromosomal aberrations observed at 
this locus in cancer cells fall in three general categories, simple mutations (amino acid 
substitution, insertion or deletion), promoter methylation, and deletions larger than 100 base 
pairs (STRANSKY et al. 2011; MOUNTZIOS et al. 2014; CICENAS et al. 2017). Remarkably, in 
some cancers, over half of the chromosomal aberrations that span the CDKN2A locus are 
large deletions (CONRAD et al. 2010; GAST et al. 2010; LEE et al. 2015). 
 
Recently CDKN2A breakpoints have been reported in melanoma (XIE et al. 2016) and 
pancreatic cancers (NORRIS et al. 2015a), but we still lack a comprehensive analysis in different 
cancers. The COSMIC (Catalogue of Somatic Mutations in Cancer) database deposits cancer 
genomes data from different sources, including the ICGC (International Cancer Genome 
Consortium). In this report, we queried the COSMIC database which reports CNVs generated 
using an Affymetrix SNP6.0 array and analyzed with two algorithms, PICNIC and ASCAT and 
generated a map of the breakpoints in the CDKN2A deletions found in different cancers (FORBES 
et al. 2016; FORBES et al. 2017)(http://cancer.sanger.ac.uk/cosmic). The deletions have a median 
length of 1,255,650bps. For most of these deletions, the telomere proximal breakpoints map to a 
small chromosomal region (Chromosomal coordinates: Chr9:20000000-22000000) left of 
CDKN2A where the genes MTAP and MIR31HG are located. The right breakpoints spread over 
a larger region centromere proximal of CDKN2A. The fact that these deletions are not cancer 




MATERIALS AND METHODS 
 
Data analysis. For this analysis, we relied on the data presented on Catalogue of Somatic 
Mutations in Cancer (COSMIC) website (http://cancer.sanger.ac.uk/cosmic). For the data 
presented in Figure 1A we used the tool “Cancer Browser” then interrogated every cancer 
visually for the top 15 mutated genes. We recorded how many times mutation in a gene appeared 
in each cancer. For the data in Figure 1B we recorded all the samples that had any CDKN2A 
mutation (CNV, point mutation, etc.) from all sequenced cancer samples. Figure 1C shows the 
subset of the CDKN2A samples in Figure 1B that show only homozygous deletion. 
 
Deletion breakpoints were downloaded from the COSMIC CONAN (Copy Number 
Analysis) database present on the website (https://cancer.sanger.ac.uk/cosmic/conan/search). 
All deletion breakpoints for CDKN2A were downloaded as an Excel file. For the data in Figure 
2 the search term was “9:1-40000000” (Genomic Region). For the data in Figures 3, 4, 5 and 6 
the search term was “CDKN2A” (HGNC Gene Symbol). All data were exported as CSV 
format. The data deposited on CONAN were derived from an Affymetrix SNP 6.0 Array and 
analyzed with PICNIC (GREENMAN et al. 2010) and ASCAT (VAN LOO et al. 2010). 
 
The genomic DNA coordinates snapshot presented in Figure 5 was downloaded from 
UCSC genome browser (http://genome.ucsc.edu/cgi-bin/hgGateway) with the search prompt 
“chr9:18,000,000-32,500,000”. The following tracts were on: Base position (dense), 
GENECODE V24 (pack), GTEx Gene (dense), and Segmental Dups (pack). 
All data were analyzed and graphed in Excel. 
 
Raw data availability. The data can be accessed on COSMIC CONAN or UCSC Genome 
Browser using the prompts described in the above Data Analysis section. The COSMIC files can 
be downloaded in .csv format. Each file contains 8 columns. The “# Sample” column lists the 
cancer subject identifier. The “Tissue” column lists the cancer tissues analyzed. The “Segment 
start” and “Segment end” columns list the chromosomal coordinates for the aberrations. These 
coordinates are at the resolution of the array. The “Total copy number” column lists the number 
of alleles identified. The “Minor allele” column represents the copies of the least frequent allele. 
The “Classification” column lists the type of aberration: HD=homozygous deletion, AMP= 





A high percentage of chromosomal aberrations that include the CDKN2A locus are 
homozygous deletions. Interrogation of the COSMIC mutation database for the GRCh38 
version of the human genome assembly revealed the top 15 mutated loci in 45 different cancer 
tissues (Fig. 1A). Of these 15 loci, the most prominent were TP53, which appeared in 36 tissues, 
and CDKN2A, which appeared in 18 tissues. COSMIC reports data for cancer genomes of 
several clinical samples from each tissue. When we examined the tissue distribution of CDKN2A 
aberrations independently, we found that the cancer samples with the highest percentage of 
CDKN2A aberrations were pleura (38%) and skin (18%) (Fig. 1B). The central nervous system 
(CNS) came in third with 12% of the sequenced samples having aberrations in the CDNK2A 
locus. However, the CNS had the most sequenced samples (6502 total samples). When we 
categorized the type of DNA damage responsible for the reported CDKN2A aberrations, we 
found that pleura showed 76% and skin showed 74% homozygous deletions (Fig. 1C). 
Furthermore, 50% of the CNS aberrations were large homozygous deletions; the remaining 
percentages representing non-deletion types of aberrations (e.g. point mutations). 
 
A concentration of CNV breakpoints in a narrow region on Chromosome 9. To 
understand whether Chromosome 9 is more prone to breaking in certain regions, we first 
analyzed the distribution of the breakpoints in all cancers reported on COSMIC (Fig. 2). We 
used data deposited on the Copy Number Analysis (CONAN) database that catalogues only the 
copy number variations (CNVs) (FORER et al. 2010) acquired with an Affymetrix SNP6.0 array 
and reports CNV segment start and segment end for all breakpoints. When we generated scatter 
plots of both the left and right breakpoints of the p arm of Chromosome 9, we found that many 
concentrates in a narrow region between coordinates 20000000 and 25000000 (Fig.2 A, B). Note 
that this pattern is unique to this region and is not found anywhere on the p arm of Chromosome 
9. 
 
Mapping the position of breakpoints to the left and right of CDKN2A. The high 
incidence of homozygous deletions that span the CDNK2A locus as well as the concentration of 
breakpoints found here suggest that the chromosome is prone to breaking in this region. The 
Chromosome 9 p21.1 and p21.2 (Fig.3A) regions have been previously reported to be hotspots 
for large genomic aberrations (SASAKI et al. 2003; LEE et al. 2015). We next analyzed the CNVs 
that include only the CDKN2A locus. Out of a total of 1479 aberrations reported for the 
CDKN2A locus in all cancers tested, 20 (1.35%) are amplifications (AMP), 1397 (94.46%) are 
homozygous deletions (HD) and 62 (4.19%) are loss of heterozygosity (LOH). When we 
mapped all the reported CNVs for the CDNK2A locus, we found that, unlike LOH and AMP, 
HD aberrations localize to a narrow region of the p arm of Chromosome 9 with only two 
homozygous deletions extending past the 9p21.1 region (Fig. 3B, C). Furthermore, the types of 
aberrations are not tissue specific. 
 
A close analysis of the homozygous deletions reveals that the break interval on the left 
side of CDKN2A (telomere proximal) maps to a much narrower region than the right 
(centromere proximal) break interval (Fig. 3B). Note that this is not a consequence of graphing 
method because in this figure each line shows position start and position end of the homozygous 
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deletion. Clearly, the left breakpoints are more clustered that the right breakpoints 
(Supplementary Figure S1). 
 
Analysis of the chromosomal region spanning the left and right breakpoints. We 
next analyzed the chromosomal region where most of the breakpoints are found using a snapshot 
from the UCSC genome browser (Fig. 4A). The break interval where most left breakpoints occur 
includes the MTAP, IFN transcripts, and MIR31HG while the right breakpoints include 
ELAVL2, and TEK genes. When we graphed only the left break point interval for all reported 
CDKN2A homozygous deletions, we found that it clusters within 2.5Mbs (chromosomal 
coordinates 19400000-22000000) (Fig. 4B). The right breakpoint spans over a region (Ch9: 
21977195-32942228, approx. 10965033bp) which is about four times larger than the region 
spanning the left breakpoint (Fig.4 A, B). Figure 4 shows the breakpoint density as number of 
breaks per genomic base pair. Clearly most of the left breakpoints are concentrated in the MTAP 
region. 
 
We next calculated the percentage of breakpoints in each region. Most left break points 
(1098/1398, 78.5%) occur approximately between coordinates 20995956-21937651, which is 
just under 1Mb (Fig. 4B). A smaller percentage of breakpoints (204/1398, 14.6%) occur in the 
region of the FOCAD, MLLT3, and SLC24A2 loci. Few breakpoints (96/1398, 6.9%) occur 
between CDKN2A and the end of MTAP. Within the right region we find that 70.7% of the 
breakpoints occur between CDKN2A and ELAVL2, 1.6% occur in the ELAVL2 region, 15.4% 
occur between ELAVL2 and the TEK region and 1.36% occur in the TEK region. The rest of the 
breakpoints are to the right of the TEK region. 
 
We next analyzed the nature of the repetitive elements in this region. We did not see an 
obvious concentration of SINE, LINE and LTR elements (data now shown). However, we did 
see a high concentration of segmental duplications that localize within the IFNA transcripts 
region, where about 25% of the left breakpoints are found and within the TEK region where only 
1.36% of right breakpoints are found (Fig.4A). Segmental duplications have been proposed to 
arise from repair of damaged DNA replication forks (PAYEN et al. 2008; COSTANTINO et al. 
2014). A correlation between the other approximately 74% of the breakpoints and segmental 
duplications cannot be made. 
 
Correlation of chromosomal coordinates and deletion size. We next tried to 
understand whether there is any relationship between the size of the homozygous deletion and 
the position of the breakpoints. A correlation between the right and the left breakpoints showed 
that most breakpoints concentrate just to the left and right of CDKN2A (Fig.5A). Indeed, when 
we graphed the deletions by size, we did find that most of them are short (approximately 50%) 
with the breakpoints just to the left and right of CDKN2A (Fig. 5B). Remarkably, the short 
homozygous deletions have their left break point in the MTAP region telomere proximal of 
CDKN2A. Furthermore, we find that the homozygous deletion size increase is determined 
primarily by the position of the right breakpoint (Fig.6). Note that the left breakpoints remain 
concentrated in a small region while the right breakpoints move further and further to the right 





Here we provide evidence that the left breakpoints of homozygous deletions that include 
the CDKN2A locus are enriched in a region telomere proximal of the CDKN2A locus. Previous 
analyses have identified such aberrations in distinct tumors but here we present a more 
comprehensive map of these aberrations in a multitude of cancers. We show that these 
aberrations are not cancer specific but are probably related to the structure or other molecular 
transactions in the chromosomal region in which they occur. 
 
Inactivation of the MLL (Mixed Lineage Leukemia) and related genes have been 
identified in different forms of leukemias (WINTERS AND BERNT 2017). Many of these genes are 
inactivated by various translocations which produces chimeric mRNAs. The most famous is the 
Philadelphia chromosome translocation which produces a fusion between ABL1 and BCR1 
(KANG et al. 2016). Further analysis of translocation in leukemia cancers led to identification of a 
plethora of other genes which were named after the point of translocation. This includes MLLT3 
(Multiple Lineage Leukemia Translocated to Ch. 3) (IIDA et al. 1993). MLLT3 characterized by 
tri-nucleotide repeats which may facilitate these forms of Translocations (WALKER et al. 1994). 
Several non-reciprocal translocations between MLLT3 and other chromosome loci have been 
identified (MEYER et al. 2013). The presence of an MLLT3 gene in the vicinity of CDKN2A may 
explain why some of the breakpoints localize in this region but does not explain most of the 
breakpoints which occur in the MTAP region or between MTAP and MIR31HG. Remarkably, 
MTAP is the only transcript that collides with CDKN2A which raises the possibility that 
collisions between transcriptional machineries may lead to a higher incidence of breaks in this 
region. However, in this analysis we do not have any data for this conclusion. 
 
MIR31HG encodes a long-non-coding RNA with oncogenic properties that represses 
expression of p16(MONTES et al. 2015). MIR31HG dysregulation has been identified in many 
cancers including pancreatic (MONTES et al. 2015; NIE et al. 2016; YANG et al. 2016). Thus, it 
appears that the homozygous deletion events seen here simultaneously inactivate both CDKN2A 
and its regulators. MTAP encodes the enzyme methylthioadenosine phosphorylase which is 
required early in the purine biosynthesis pathway (BERTINO et al. 2011). Deletion of MTAP has 
been identified in many forms of cancers and is usually co-deleted with the CDKN2A locus 
(CHEN et al. 1996). 
 
Several molecular mechanisms have been identified that can lead to homozygous 
deletions. One of the most preeminent mechanism reported in human cells to cause deletions is 
Microhomology Mediated Break Induced Replication (MMBIR) (HASTINGS et al. 2009a; 
VERDIN et al. 2013). MMBIR has also been proposed to be the major cause of copy number 
variations (HASTINGS et al. 2009a; ZHANG et al. 2009a; ZHANG et al. 2009b). What is attractive 
about MMBIR is that it does not require two ended breaks, and potential breaks resulting from 
replication fork stalling or collapsing usually produces one ended breaks. Because these data 
were generated with microarrays, breakpoints are only at the precision of the arrays which is at 




Canonical break induced replication (BIR) requires more extensive homologous regions 
in the vicinity of 300 nucleotides (MEHTA AND HABER 2014). We visually inspected all 
breakpoints for longer tracts of homology, but we did not see large regions of homology 
characteristic of repair by break induced replication, or other forms of homologous 
recombination such as single strand annealing (MEHTA AND HABER 2014; BHARGAVA et al. 
2016). Non-homologous end joining (NHEJ), a form of repair that is very efficient in human 
cells, is another mechanism that can cause copy number variations (HASTINGS et al. 2009b). A 
recently described Trans-Flip mechanism has been proposed to generate mainly short 
homozygous deletions (NORRIS et al. 2015b). We do find that the CDKN2A homozygous 
deletions are short and they fall in the range of the those proposed to occur by TransFlip so it is 
possible that this mechanism may contribute to these aberrations. 
 
Here we provide evidence that the left breakpoints of homozygous deletions that include 
the CDKN2A locus are enriched in a region to the left of CDKN2A where MTAP is found. 
Human genomes are characterized by numerous other forms of chromosomal aberrations many 
of which include duplications and deletions. Deletion hotspots as the one described here are most 









Figure 1. Major types of DNA damage. Three major types of DNA damage can be 
encountered in a double stranded chromosome. In point mutation the base on one strand has 
changed such that it violates the rules of base pairing A-T and G-C. In this case C has changed 
to T. In a single strand break, one of the two strands breaks. This can be easily repaired 
because the information is preserved on the other strand. In this case a T would be inserted 
opposite A. A double strand break constitutes severing of both strands. In this diagram the 











Figure 2. Microscopic chromosome karyotypes (Source: Biology Learning Center). (A) 
Each of the 22 chromosome pairs and the sex XY chromosomes are painted with a different 
color to be distinguished from each other under the microscope. (B) A cancer cell has 
reorganized its chromosomes such that many can no longer be classified as a normal 1 to 22 








Figure 3. Pathways of repair of DNA double strand breaks. A diploid cell with two 
homologous chromosomes, black and red, sustains a double strand break (DSB) in the black 
chromosome (1). The DSB is first resected to expose ssDNA required for invasion of donor 
regions (2). If direct repeats (shaded areas) exist on the same chromosome, the break may be 
repaired by single strand annealing (SSA) (3). If repair fails, the chromosome may be lost (4). 
When homology is found elsewhere or on the other homologue (red), the broken ends may 
invade this region (the donor sequence) (5). In synthesis-dependent strand annealing (SDSA) 
(6) the invading strand may copy a small region then release and re-anneal. In break-induced 
replication (BIR) (7) the invading strand may copy to the end of the red chromosome. In this 
case the right portion of the broken black chromosome is lost. Occasionally a more complex 
double Holiday Junction (dJH) may be established (8), the resolution of which can result in 
crossovers (CO) or non-crossovers (NCO). Note that some of these repair outcomes may lead to 
loss of heterozygosity meaning that the black sequence has been converted to red. If the red 
sequence contains a recessive non-functional allele, some of these outcomes will convert the 
functional black allele to the non-functional red allele resulting in complete inactivation of the 






Figure 4. The CDKN2A locus is mutated in many cancers. (A) The top 15 mutations that 
appeared in 45 different cancers as reported by the COSMIC database. (B) Percent cancer 
samples that have any CDKN2A aberration out of all sequenced samples in each tissue. Only 
the tissues that have over 1% CDKN2A aberrations are shown. (C) Percent samples with 




Figure 5. Many CNV breakpoints concentrate in a narrow range on Chromosome 9. 
Scatter graphs of all CONAN reported CNV breakpoints on the p arm of Chromosome 9. (A) 
Left breakpoint (proximal to telomere of p arm) of CNVs. Note that there is a concentration of 
breakpoints between coordinates 20,000,000 and 25,000,000. (B) Right breakpoint 






Figure 6. Chromosomal aberrations that include the CDKN2A locus. (A) General map of 
the chromosome 9 p arm. Chromosomal coordinates are shown in base pairs. (B) A map of all 
the chromosomal aberrations reported on CONAN by tissue type. Included are loss of 
heterozygosity (LOH), homozygous deletion (HD) and amplification (AMP). The lines 
represent the aberration between the left and right breakpoints as reported on CONAN. (C) 








Figure 7. Distribution of breakpoints of CNVs that include CDKN2A over the 
chromosomal region. (A) UCSC genome browser snapshot of the chromosomal regions 
neighboring CDKN2A with a window between coordinates 9:18,000,000-32,500,000. 
Showing are the base positions, coding genes, GTEx Gene expression and segmental 
duplications. (B) Density of breakpoint distribution to the left and right of CDKN2A. Because 
this graph is not superimposable on the genome snapshot in A some of the genomic loci are 





Figure 8. Correlation between the left breakpoint and the right breakpoint. (A) X-Y 
scatter graph of the left and right breakpoint for all homozygous deletions that include 
CDKN2A. X-axis shows the chromosomal coordinates left of CDKN2A and Y-axis the 
coordinates right of CDKN2A. (B) A graph of the homozygous deletions by size. Note that 






Figure 9. Correlation of breakpoints and homozygous deletion size. Graph showing 
correlation between length of homozygous deletion (orange) its left breakpoint (blue) and its 
right breakpoint (grey). Note that the left breakpoints are clustered, and the deletions size 






Supplementary Figure S1. The left breakpoints of homozygous deletions are 
concentrated to a narrow region than the right breakpoints. (A) Graph showing the 
distribution of homozygous deletions organized by the position of the left breakpoints. 
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